AIRS
AirSculpt Technologies, Inc.
AIRS trails on the overall score without a compensating advantage in the available component scores.
OSCR
Oscar Health, Inc.
OSCR has the edge over AIRS overall, supported by stronger fundamentals.
AIRS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Weak |
AIRS's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
AIRS PE Valuation
AIRS has no meaningful PE right now: it lost money over the past year.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
AIRS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect AIRS's losses to grow, with revenue holding steady.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
OSCR has the edge over AIRS on the outlook, with more favorable earnings and revenue expectations.
AIRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.13 | +$0.16 |
| Q2 2026 | -$0.18 | +$0.06 |
| Q1 2026 | -$0.17 | +$0.12 |
| Q4 2025 | -$0.19 | -$0.05 |
| Q3 2025 | -$0.29 | -$0.15 |
| Q2 2025 | -$0.24 | -$0.17 |
| Q1 2025 | -$0.29 | -1550% |
| Q4 2024 | -$0.14 | -$0.06 |
AIRS is still losing money, but far less than before: $0.13 per share over the past year, against $0.29 at its worst in early 2025.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over AIRS on earnings quality, reporting a profit while its opponent remains loss making.
AIRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $31.9M | -8.7% |
| Q2 2026 | $42.9M | -2.5% |
| Q1 2026 | $39.4M | 0% |
| Q4 2025 | $33.4M | -15% |
| Q3 2025 | $35M | -18% |
| Q2 2025 | $44M | -14% |
| Q1 2025 | $39.4M | -17% |
| Q4 2024 | $39.2M | -18% |
AIRS's revenue has slid since its 2023 peak: $32M last quarter, down 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -13% | +15 points |
| Q2 2026 | -0.1% | -1.9 points |
| Q1 2026 | -4.6% | -0.5 points |
| Q4 2025 | -3% | +7.5 points |
| Q3 2025 | -28% | -19 points |
| Q2 2025 | 1.8% | +12 points |
| Q1 2025 | -4% | -27 points |
| Q4 2024 | -11% | -14 points |
AIRS's operating margin was −13% last quarter, up 15 points from the same quarter a year ago, near the bottom of its range since 2020.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over AIRS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over AIRS on profitability, with a higher operating margin.
AIRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.7M | -$3.3M |
| Q2 2026 | -$1.5M | -131% |
| Q1 2026 | $5.2M | +$6.3M |
| Q4 2025 | -$2.6M | -$1.8M |
| Q3 2025 | -$405K | +$2.7M |
| Q2 2025 | $4.7M | +$5.3M |
| Q1 2025 | -$1M | -157% |
| Q4 2024 | -$815K | -127% |
AIRS has burned cash in six of the last eight quarters: −$3M over the past year, against $2M the year before.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over AIRS on cash generation, producing positive trailing cash flow while its opponent burns cash.
AIRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +1.8M shares |
| 1 year | +16% | +10.1M shares |
| 3 years | +28% | +15.8M shares |
| 5 years | +31% | +17.2M shares |
| Available history | +30% | +16.9M shares |
AIRS has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
AIRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.3x | High |
| Q1 2026 | 35.7x | High |
| Q4 2025 | 39.0x | High |
| Q2 2025 | 12.3x | High |
| Q4 2024 | 6.1x | High |
| Q3 2024 | 4.2x | High |
| Q2 2024 | 3.1x | Elevated |
| Q1 2024 | 2.0x | Moderate |
AIRS's net debt is about 4.3 years of its operating earnings (EBITDA), down from 6.1 years a year ago.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has the edge over AIRS on leverage, with a lower net debt burden relative to earnings.
AIRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.5 | Neutral |
| Stochastic | 7.2 | Oversold |
AIRS's weekly RSI is 32 (neutral) and its Stochastic is 7 (oversold).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
AIRS PE vs Healthcare Sector
| Metric | AIRS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
AIRS has no meaningful PE right now: it lost money over the past year.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
AIRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.35 | 47% below |
| 20 week MA | $2.74 | 74% below |
| 50 week MA | $2.95 | 76% below |
| 100 week MA | $4.09 | 82% below |
| 200 week MA | $5.09 | 86% below |
AIRS is in a downtrend: it's below all five of its weekly moving averages, and 86% below its 200-week average.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over AIRS on trend strength, trading above more of its moving averages.
AIRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $15.9 | $14.5 | -8.7% |
| 2022 | $14.5 | $3.32 | -77% |
| 2023 | $3.32 | $7.49 | +126% |
| 2024 | $7.49 | $5.58 | -26% |
| 2025 | $5.58 | $2.03 | -64% |
| 2026 YTD | $2.03 | $0.72 | -65% |
AIRS's yearly returns have swung widely, from +126% in 2023 to −77% in 2022. It's down 65% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over AIRS on returns for 2026, with the stronger performance.